Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Subr

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Cancer Immunology, Immunotherapy : CII|April 26, 2006
Treatment with HPMA copolymer-based doxorubicin conjugate containing human immunoglobulin induces long-lasting systemic anti-tumour immunity in miceMilada Sirova, Jiri Strohalm, Vladimir Subr, et al.
Neoplasia (New York, N.Y.)|October 13, 2006
Effect of intratumoral injection on the biodistribution and the therapeutic potential of HPMA copolymer-based drug delivery systemsTwan Lammers, Peter Peschke, Rainer Kühnlein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2002
Detection and cellular localisation of the synthetic soluble macromolecular drug carrier pHPMAMaria Kissel, Peter Peschke, Vladimir Subr, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 27, 2009
Coating of adenovirus type 5 with polymers containing quaternary amines prevents binding to blood componentsVladimir Subr, Libor Kostka, Tom Selby-Milic, et al.
Nanomedicine (London, England)|December 15, 2010
HPMA-based polymer therapeutics improve the efficacy of surgery, of radiotherapy and of chemotherapy combinationsTwan Lammers, Vladimir Subr, Karel Ulbrich, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2007
Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptorJoanne Morrison, Simon S Briggs, Nicola Green, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 12, 2007
Effect of radiotherapy and hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systemsTwan Lammers, Peter Peschke, Rainer Kühnlein, et al.
Biomacromolecules|January 19, 2026
Lopinavir Derivative as Potent P-gp Inhibitor Enables Delivery through HPMA Copolymer Conjugates and Overcoming Tumor Chemoresistance to Conventional Cytostatic DrugsDaniil Starenko, Libor Kostka, Katerina Behalova, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 3, 2011
Tumour necrosis factor-alpha increases extravasation of virus particles into tumour tissue by activating the Rho A/Rho kinase pathwayTakahiro Seki, Fionnadh Carroll, Sam Illingworth, et al.
Journal of the National Cancer Institute|October 31, 2013
Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasoundRobert Carlisle, James Choi, Miriam Bazan-Peregrino, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Cancer Immunology, Immunotherapy : CII|April 26, 2006
Treatment with HPMA copolymer-based doxorubicin conjugate containing human immunoglobulin induces long-lasting systemic anti-tumour immunity in miceMilada Sirova, Jiri Strohalm, Vladimir Subr, et al.
Neoplasia (New York, N.Y.)|October 13, 2006
Effect of intratumoral injection on the biodistribution and the therapeutic potential of HPMA copolymer-based drug delivery systemsTwan Lammers, Peter Peschke, Rainer Kühnlein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2002
Detection and cellular localisation of the synthetic soluble macromolecular drug carrier pHPMAMaria Kissel, Peter Peschke, Vladimir Subr, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 27, 2009
Coating of adenovirus type 5 with polymers containing quaternary amines prevents binding to blood componentsVladimir Subr, Libor Kostka, Tom Selby-Milic, et al.
Nanomedicine (London, England)|December 15, 2010
HPMA-based polymer therapeutics improve the efficacy of surgery, of radiotherapy and of chemotherapy combinationsTwan Lammers, Vladimir Subr, Karel Ulbrich, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2007
Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptorJoanne Morrison, Simon S Briggs, Nicola Green, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 12, 2007
Effect of radiotherapy and hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systemsTwan Lammers, Peter Peschke, Rainer Kühnlein, et al.
Biomacromolecules|January 19, 2026
Lopinavir Derivative as Potent P-gp Inhibitor Enables Delivery through HPMA Copolymer Conjugates and Overcoming Tumor Chemoresistance to Conventional Cytostatic DrugsDaniil Starenko, Libor Kostka, Katerina Behalova, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 3, 2011
Tumour necrosis factor-alpha increases extravasation of virus particles into tumour tissue by activating the Rho A/Rho kinase pathwayTakahiro Seki, Fionnadh Carroll, Sam Illingworth, et al.
Journal of the National Cancer Institute|October 31, 2013
Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasoundRobert Carlisle, James Choi, Miriam Bazan-Peregrino, et al.
Pageof 3